CONTINUUS Pharmaceuticals is leveraging the experience, know-how, and novel process technologies developed at the Novartis-MIT Center for Continuous Manufacturing to advance the state of manufacturing within the pharmaceutical industry.
We specialize in end-to-end Integrated Continuous Manufacturing (ICM), with the application of novel process technologies that enable rapid production of pharmaceuticals at significantly reduced costs and better quality. With ICM, we improve affordability and accessibility of pharmaceuticals on a global scale.
It is our vision that, through our advanced technology platform, we can help innovator and generic drug companies develop and manufacture higher quality drugs in a more efficient and cost-effective manner. Our offering is tailored to provide clients with the best solutions for their pharmaceutical development and manufacturing needs. They include the following:
Our solutions provide clients with a range of opportunities with varying risk-reward profiles. Targeted solutions will help clients solve specific challenges encountered with current batch processes, while implementation of ICM lines will completely transform manufacturing operations.